GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beijing Beilu Pharmaceutical Co Ltd (SZSE:300016) » Definitions » EBITDA Margin %

Beijing Beilu Pharmaceutical Co (SZSE:300016) EBITDA Margin % : 6.84% (As of Sep. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Beijing Beilu Pharmaceutical Co EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Beijing Beilu Pharmaceutical Co's EBITDA for the three months ended in Sep. 2024 was ¥17.5 Mil. Beijing Beilu Pharmaceutical Co's Revenue for the three months ended in Sep. 2024 was ¥255.8 Mil. Therefore, Beijing Beilu Pharmaceutical Co's EBITDA margin for the quarter that ended in Sep. 2024 was 6.84%.


Beijing Beilu Pharmaceutical Co EBITDA Margin % Historical Data

The historical data trend for Beijing Beilu Pharmaceutical Co's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Beilu Pharmaceutical Co EBITDA Margin % Chart

Beijing Beilu Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 26.75 26.76 26.67 14.43 4.09

Beijing Beilu Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.03 -32.65 14.30 7.10 6.84

Competitive Comparison of Beijing Beilu Pharmaceutical Co's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Beijing Beilu Pharmaceutical Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beijing Beilu Pharmaceutical Co's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Beijing Beilu Pharmaceutical Co's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Beijing Beilu Pharmaceutical Co's EBITDA Margin % falls into.



Beijing Beilu Pharmaceutical Co EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Beijing Beilu Pharmaceutical Co's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=36.446/890.718
=4.09 %

Beijing Beilu Pharmaceutical Co's EBITDA Margin % for the quarter that ended in Sep. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Sep. 2024 )/Revenue (Q: Sep. 2024 )
=17.506/255.787
=6.84 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Beijing Beilu Pharmaceutical Co  (SZSE:300016) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Beijing Beilu Pharmaceutical Co EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Beijing Beilu Pharmaceutical Co's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Beilu Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 3, Shuiyuan West Road, Miyun District, Beijing, CHN, 100082
Beijing Beilu Pharmaceutical Co Ltd is engaged in the research and development, production, and sales of pharmaceutical products. The products of the company are contrasted agent series, psychotropic, and hypoglycemic products which include iopamidol injection, iodixanol injection, and reglinide tablets.
Executives
Zong Li Directors, executives
Hong Cheng Jie Director
Duan Xian Zhu Directors, executives
Zhu Zhi Director
Wang Dai Xue Director
Li Hong Directors, executives
Liu Ning Directors, executives
Wu Rui Hua Directors, executives
Wu Jie Executives
Liu Dong Long Supervisors
Hong Wei Directors, executives

Beijing Beilu Pharmaceutical Co Headlines

No Headlines